MXCAX
Price
$13.50
Change
-$0.21 (-1.53%)
Updated
Nov 13 closing price
Net Assets
14.97M
VEMRX
Price
$115.08
Change
-$0.80 (-0.69%)
Updated
Nov 13 closing price
Net Assets
141.19B
Interact to see
Advertisement

MXCAX vs VEMRX

Header iconMXCAX vs VEMRX Comparison
Open Charts MXCAX vs VEMRXBanner chart's image
BlackRock Emerging Markets Ex-Chn Inv A
Price$13.50
Change-$0.21 (-1.53%)
VolumeN/A
Net Assets14.97M
Vanguard Emerging Mkts Stock Idx InsPlus
Price$115.08
Change-$0.80 (-0.69%)
VolumeN/A
Net Assets141.19B
MXCAX vs VEMRX Comparison Chart in %
View a ticker or compare two or three
VS
MXCAX vs. VEMRX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXCAX is a Buy and VEMRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 141B vs. MXCAX (15M). VEMRX pays higher dividends than MXCAX: VEMRX (2.80) vs MXCAX (0.58). MXCAX was incepted earlier than VEMRX: MXCAX (3 years) vs VEMRX (15 years). MXCAX (3.35) is less costly to investors than VEMRX (0.07). MXCAX is a more actively managed with annual turnover of: 86.00 vs. VEMRX (8.00). MXCAX has a lower initial minimum investment than VEMRX: MXCAX (1000) vs VEMRX (100000000). VEMRX annual gain was more profitable for investors over the last year : 22.70 vs. MXCAX (19.21).
MXCAXVEMRXMXCAX / VEMRX
Total Expense Ratio1.120.071,600%
Annual Report Gross Expense Ratio3.350.074,786%
Fund Existence3 years15 years-
Gain YTD27.53524.460113%
Front Load5%N/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets15M141B0%
Annual Yield % from dividends0.582.8021%
Returns for 1 year19.2122.7085%
Returns for 3 yearsN/A51.08-
Returns for 5 yearsN/A28.16-
Returns for 10 years253.9888.60287%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPVG5.950.15
+2.59%
TRIPLEPOINT VENTURE GROWTH BDC Corp
PRO23.13N/A
N/A
Pros Holdings
MRVL89.33N/A
N/A
Marvell Technology
ITRM0.60-0.01
-1.67%
Iterum Therapeutics plc
ALKS31.41-2.41
-7.11%
Alkermes plc